Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AmberHealth vs Next Vial

AmberHealth
Graded #31

Higher grade

vs+23.60000000000001
Next Vial
Graded #345

Lower grade

The verdict

AmberHealth takes it — 82.9/100 to 59.3/100.

AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmberHealth +50
90
40
Dose & formulationAmberHealth +28
80
52
Clinical oversightNext Vial +3
79
82
Labs & monitoringAmberHealth +26
78
52
FulfillmentEven
86
86
Contract termsAmberHealth +27
82
55
AmberHealth · left barNext Vial · right bar

The numbers

MetricAmberHealthNext Vial
WeighScore82.9/10059.3/100
GradeB−C
Scorecard rank#31#345
Semaglutide$100/mo$250/mo (compounded)
Tirzepatide$175/moNot disclosed
CoverageAll 50 states49 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AmberHealth

Graded #31 · B−

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $175
  • Monitoring detail sparse
Next Vial

Graded #345 · C

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Where it loses points

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard